Perspective on valuation, deal structure, and sector dynamics across the middle market — written for founders, owners, and investors.
Details the step-by-step process for taking a company public, from initial letter of intent and broker-dealer commitment through private placement, SEC
January 28, 2015Public companies and their officers must track required SEC, NASD, and FINRA filings carefully. Learn which forms apply, what triggers them, and the penalties
January 26, 2015Going public should be a milestone of building real value, not the goal itself. Explore why prioritizing company fundamentals over IPO timing produces better
January 23, 2015Profiles 1-Page founder Joanna Weidenmiller's journey from $3M in Silicon Valley VC funding to a reverse merger on the Australian Securities Exchange, reaching
January 23, 2015Learn how to manage accounting costs during the pre-incorporation phase of a public offering, including how to find qualified PCAOB accountants while keeping
January 21, 2015This week's finance and markets recap covers 2016 deal activity forecasts, Airbus-Uber partnerships, leveraged buyout lending pullbacks, and trends affecting
January 20, 2015Explore why some U.S.-based firms choose the Australian Securities Exchange for reverse merger public offerings and what advantages and risks this cross-border
January 19, 2015Learn how Alternative Public Offerings combine reverse mergers with PIPE transactions to give private companies a faster, lower-cost path to going public than
January 19, 2015Survey the top industry sectors actively pursuing reverse mergers, including healthcare, pharma, biotech, tech, and energy, with examples of current deal
January 16, 2015Spreading financing inquiries across too many sources can hurt your credibility with lenders. Learn how to strategically hedge your options when financing a
January 3, 2015As Bitcoin gains legitimacy as a currency, could it serve as deal consideration in M&A transactions? This article examines the potential role of cryptocurrency
December 27, 2014Examine how low oil prices driven by the OPEC-shale conflict are forcing consolidation across the US oil industry and the broader economic consequences for
December 26, 2014FINRA warns investors about e-cigarette pump-and-dump schemes. Learn how to spot red flags in reverse-merger stocks and protect yourself from fraudulent
December 24, 2014Discover legitimate methods for accessing pre-IPO stock and understand where individual investors fit in the capital chain before a company goes public.
December 22, 2014Explore affordable and simplified methods for taking a company public, making the process accessible to small and mid-sized business owners beyond traditional
December 17, 2014Learn the key advantages of SPACs over traditional reverse mergers, including investor protections, capital requirements, and how they benefit both target
December 15, 2014Taking a company public requires complete C-suite alignment. Explore the key questions executives must answer about management readiness, growth planning, and
December 13, 2014Going public through a reverse merger or direct public offering requires careful preparation well in advance, including corporate structure conversion and
December 12, 2014Short-term thinking after a reverse takeover is a leading cause of RTO failure. This post argues for sustainable post-deal strategies that prioritize long-term
December 11, 2014Chasing hot trends and microcap fads can cost investors dearly. Learn why disciplined deal selection matters more than momentum, especially in speculative
December 10, 2014An interview with Commenda Capital, a merchant bank formed by merging Batten Capital and Runningen Associates to serve middle-market companies with debt and
December 6, 2014Public companies face extensive SEC disclosure obligations beyond annual and quarterly reports. Learn the key downsides of going public and how transparency
November 25, 2014After submitting a public company registration, SEC and NASD comments trigger a review process that can include multiple rounds of revisions before approval is
November 3, 2014Examine the iBio pump-and-dump case tied to Ebola drug hype, and understand how misleading press releases and microcap stock manipulation lead to investor
November 3, 2014